---
title: "Any-to-All MRI Synthesis: A Unified Foundation Model for Nasopharyngeal Carcinom"
date: 2026-02-10
arxiv: "2602.08822v1"
category: "cs.CV"
model: "google/gemma-3-27b-it:free"
---

# Any-to-All MRI Synthesis: A Unified Foundation Model for Nasopharyngeal Carcinoma and Its Downstream Applications

## ğŸ“– ë…¼ë¬¸ ì •ë³´

| í•­ëª© | ë‚´ìš© |
|------|------|
| **ì €ì** | Yao Pu, Yiming Shi, Zhenxi Zhang, Peixin Yu, Yitao Zhuang... |
| **ë°œí‘œì¼** | 2026-02-09 |
| **arXiv** | [2602.08822v1](https://arxiv.org/pdf/2602.08822v1) |
| **ì¹´í…Œê³ ë¦¬** | cs.CV |

---

## ğŸ“ ì´ˆë¡ (Abstract)

Magnetic resonance imaging (MRI) is essential for nasopharyngeal carcinoma (NPC) radiotherapy (RT), but practical constraints, such as patient discomfort, long scan times, and high costs often lead to incomplete modalities in clinical practice, compromising RT planning accuracy. Traditional MRI synthesis methods are modality-specific, limited in anatomical adaptability, and lack clinical interpretability-failing to meet NPC's RT needs. Here, we developed a unified foundation model integrating contrastive visual representation learning and vision-language alignment (VLA) to enable any-to-all MRI synthesis. The model uses a contrastive encoder for modality-invariant representations and a CLIP-based text-informed decoder for semantically consistent synthesis, supporting any-to-all MRI synthesis via one unified foundation model. Trained on 40,825 images from 13 institutions, it achieves consistently high performance (average SSIM 0.90, PSNR 27) across 26 internal/external validation sites (15,748 images), with superior synthesis fidelity and robustness to noise and domain shifts. Meanwhile, its unified representation enhances downstream RT-relevant tasks (e.g., segmentation). This work advances digital medicine solutions for NPC care by leveraging foundation models to bridge technical synthesis and clinical utility.

---

## ğŸ” AI ë¶„ì„

## ğŸ“„ ë…¼ë¬¸ ìš”ì•½
ë³¸ ë…¼ë¬¸ì€ ë¹„ì¸ë‘ì•”(NPC) í™˜ìì˜ ë°©ì‚¬ì„  ì¹˜ë£Œ(RT) ê³„íš ì •í™•ë„ë¥¼ ë†’ì´ê¸° ìœ„í•´, MRI ëª¨ë‹¬ë¦¬í‹° ë¶€ì¡± ë¬¸ì œë¥¼ í•´ê²°í•˜ëŠ” í†µí•© íŒŒìš´ë°ì´ì…˜ ëª¨ë¸ì„ ì œì•ˆí•©ë‹ˆë‹¤. ì´ ëª¨ë¸ì€ ëŒ€ì¡°ì  ì‹œê° í‘œí˜„ í•™ìŠµê³¼ Vision-Language Alignment (VLA)ë¥¼ ê²°í•©í•˜ì—¬ ì–´ë–¤ MRI ëª¨ë‹¬ë¦¬í‹°ì—ì„œë“  ë‹¤ë¥¸ ëª¨ë‹¬ë¦¬í‹°ë¡œì˜ í•©ì„±ì„ ê°€ëŠ¥í•˜ê²Œ í•©ë‹ˆë‹¤. 13ê°œ ê¸°ê´€ì˜ 40,825ê°œ ì´ë¯¸ì§€ë¡œ í•™ìŠµëœ ëª¨ë¸ì€ ë†’ì€ ì„±ëŠ¥(SSIM 0.90, PSNR 27)ì„ ë³´ì´ë©°, íŠ¹íˆ downstream RT ê´€ë ¨ ì‘ì—…(segmentation ë“±)ì˜ ì„±ëŠ¥ í–¥ìƒì—ë„ ê¸°ì—¬í•©ë‹ˆë‹¤. ê¶ê·¹ì ìœ¼ë¡œ, ì´ ì—°êµ¬ëŠ” íŒŒìš´ë°ì´ì…˜ ëª¨ë¸ì„ í™œìš©í•˜ì—¬ NPC ì¹˜ë£Œì˜ ê¸°ìˆ ì  í•©ì„± ëŠ¥ë ¥ê³¼ ì„ìƒì  ìœ ìš©ì„±ì„ ì—°ê²°í•˜ëŠ” ë””ì§€í„¸ ì˜ë£Œ ì†”ë£¨ì…˜ì„ ì œì‹œí•©ë‹ˆë‹¤.

### ğŸ†• ìƒˆë¡œìš´ ì  (Novelty)
ê¸°ì¡´ì˜ MRI í•©ì„± ë°©ë²•ë“¤ì´ íŠ¹ì • ëª¨ë‹¬ë¦¬í‹°ì— êµ­í•œë˜ê³  í•´ë¶€í•™ì  ì ì‘ë ¥ì´ ë‚®ìœ¼ë©° ì„ìƒì  í•´ì„ ê°€ëŠ¥ì„±ì´ ë¶€ì¡±í–ˆë˜ ì ì„ ê·¹ë³µí•˜ê³ , **ë‹¨ì¼ í†µí•© ëª¨ë¸ë¡œ ëª¨ë“  MRI ëª¨ë‹¬ë¦¬í‹° ê°„ì˜ í•©ì„±ì„ ê°€ëŠ¥í•˜ê²Œ í•˜ëŠ” Any-to-All MRI Synthesis**ë¥¼ ì œì•ˆí•œ ì ì´ ê°€ì¥ í° noveltyì…ë‹ˆë‹¤. ë˜í•œ, **ëŒ€ì¡°ì  ì‹œê° í‘œí˜„ í•™ìŠµê³¼ VLAë¥¼ ê²°í•©**í•˜ì—¬ ì˜ë¯¸ì ìœ¼ë¡œ ì¼ê´€ì„± ìˆëŠ” í•©ì„±ì„ ê°€ëŠ¥í•˜ê²Œ í•œ ì ë„ ìƒˆë¡œìš´ ì‹œë„ì…ë‹ˆë‹¤.

### ğŸ’ª ê°•ì  (Strengths)
1. **ë†’ì€ ì„±ëŠ¥ ë° ì¼ë°˜í™” ëŠ¥ë ¥:** 26ê°œ ë‚´ë¶€/ì™¸ë¶€ ê²€ì¦ ì‚¬ì´íŠ¸(15,748ê°œ ì´ë¯¸ì§€)ì—ì„œ ì¼ê´€ë˜ê²Œ ë†’ì€ ì„±ëŠ¥(SSIM 0.90, PSNR 27)ì„ ë³´ì—¬, ëª¨ë¸ì˜ ì¼ë°˜í™” ëŠ¥ë ¥ì´ ë›°ì–´ë‚¨ì„ ì…ì¦í–ˆìŠµë‹ˆë‹¤.
2. **Any-to-All í•©ì„± ëŠ¥ë ¥:** ë‹¨ì¼ ëª¨ë¸ë¡œ ëª¨ë“  MRI ëª¨ë‹¬ë¦¬í‹° ê°„ì˜ í•©ì„±ì„ ì§€ì›í•˜ì—¬, ì„ìƒì  ìœ ì—°ì„±ì„ í¬ê²Œ í–¥ìƒì‹œì¼°ìŠµë‹ˆë‹¤.
3. **Downstream Task ì„±ëŠ¥ í–¥ìƒ:** MRI í•©ì„± ê²°ê³¼ê°€ RT ê´€ë ¨ downstream task (segmentation)ì˜ ì„±ëŠ¥ í–¥ìƒì— ê¸°ì—¬í•˜ì—¬, ì„ìƒì  ìœ ìš©ì„±ì„ ì…ì¦í–ˆìŠµë‹ˆë‹¤.

### âš ï¸ ì•½ì /í•œê³„ì  (Limitations)
1. **ë°ì´í„° ì˜ì¡´ì„±:** 13ê°œ ê¸°ê´€ì˜ ë°ì´í„°ë¡œ í•™ìŠµë˜ì—ˆì§€ë§Œ, ë°ì´í„° í¸í–¥(data bias) ê°€ëŠ¥ì„±ì´ ì¡´ì¬í•˜ë©°, ë‹¤ë¥¸ ë³‘ì›ì˜ ë°ì´í„°ì— ëŒ€í•œ ì„±ëŠ¥ì€ ê²€ì¦ë˜ì§€ ì•Šì•˜ìŠµë‹ˆë‹¤.
2. **ê³„ì‚° ë¹„ìš©:** íŒŒìš´ë°ì´ì…˜ ëª¨ë¸ì˜ í•™ìŠµ ë° ì¶”ë¡ ì— ìƒë‹¹í•œ ê³„ì‚° ìì›ì´ í•„ìš”í•  ê²ƒìœ¼ë¡œ ì˜ˆìƒë©ë‹ˆë‹¤.
3. **VLAì˜ êµ¬ì²´ì ì¸ êµ¬í˜„:** CLIP ê¸°ë°˜ VLAë¥¼ ì‚¬ìš©í–ˆì§€ë§Œ, VLAì˜ êµ¬ì²´ì ì¸ êµ¬í˜„ ë°©ì‹ê³¼ ì„±ëŠ¥ì— ëŒ€í•œ ìƒì„¸í•œ ë¶„ì„ì´ ë¶€ì¡±í•©ë‹ˆë‹¤. ì–´ë–¤ ì¢…ë¥˜ì˜ í…ìŠ¤íŠ¸ ì •ë³´ë¥¼ í™œìš©í–ˆëŠ”ì§€, ê·¸ë¦¬ê³  ê·¸ ì •ë³´ê°€ í•©ì„± ê²°ê³¼ì— ì–´ë–¤ ì˜í–¥ì„ ë¯¸ì¹˜ëŠ”ì§€ì— ëŒ€í•œ ì„¤ëª…ì´ ë” í•„ìš”í•©ë‹ˆë‹¤.

### ğŸ”— ë‚´ ì—°êµ¬ì™€ì˜ ì—°ê´€ì„±
ë³¸ ë…¼ë¬¸ì€ ì €ì˜ ì—°êµ¬ ë¶„ì•¼ì¸ Scientific MLLM, Vision-Language Alignment, ê·¸ë¦¬ê³  MLLMì˜ ì¶”ë¡  ëŠ¥ë ¥ í–¥ìƒ ì—°êµ¬ì™€ ë°€ì ‘í•˜ê²Œ ê´€ë ¨ë˜ì–´ ìˆìŠµë‹ˆë‹¤. íŠ¹íˆ, **VLAë¥¼ í™œìš©í•˜ì—¬ ì‹œê° ì •ë³´ë¥¼ í…ìŠ¤íŠ¸ ì •ë³´ì™€ ì—°ê²°í•˜ê³ , ì´ë¥¼ í†µí•´ ê³¼í•™ì  ë„ë©”ì¸(ì˜ë£Œ ì˜ìƒ)ì—ì„œì˜ ì¶”ë¡  ëŠ¥ë ¥ì„ í–¥ìƒì‹œí‚¤ëŠ” ì ‘ê·¼ ë°©ì‹**ì€ ì €ì˜ ì—°êµ¬ ë°©í–¥ê³¼ ì¼ì¹˜í•©ë‹ˆë‹¤. ë˜í•œ, ì´ ë…¼ë¬¸ì—ì„œ ì œì‹œëœ ëŒ€ì¡°ì  ì‹œê° í‘œí˜„ í•™ìŠµ ë°©ë²•ì€ ì €ì˜ Vision encoderì™€ Text LLM ê°„ì˜ ì •ë ¬(alignment) ì—°êµ¬ì— ì ìš©ë  ìˆ˜ ìˆëŠ” ì•„ì´ë””ì–´ë¥¼ ì œê³µí•©ë‹ˆë‹¤.

### ğŸ’¡ ì—°êµ¬ ì•„ì´ë””ì–´ ì œì•ˆ
1. **VLAì˜ í™•ì¥ ë° ê°œì„ :** CLIP ì™¸ì— ë‹¤ë¥¸ VLA ëª¨ë¸(ì˜ˆ: BLIP, ALBEF)ì„ ì‚¬ìš©í•˜ì—¬ ì„±ëŠ¥ì„ ë¹„êµí•˜ê³ , ë” íš¨ê³¼ì ì¸ VLA ë°©ë²•ì„ íƒìƒ‰í•©ë‹ˆë‹¤. íŠ¹íˆ, ì˜ë£Œ ì˜ìƒì— íŠ¹í™”ëœ í…ìŠ¤íŠ¸ ì •ë³´ë¥¼ í™œìš©í•˜ì—¬ VLA ì„±ëŠ¥ì„ í–¥ìƒì‹œí‚¤ëŠ” ì—°êµ¬ë¥¼ ì§„í–‰í•  ìˆ˜ ìˆìŠµë‹ˆë‹¤.
2. **ë°ì´í„° í¸í–¥ ì™„í™” ì—°êµ¬:** ë‹¤ì–‘í•œ ë³‘ì›ì˜ ë°ì´í„°ë¥¼ í™œìš©í•˜ì—¬ ëª¨ë¸ì„ í•™ìŠµí•˜ê³ , ë°ì´í„° í¸í–¥ì„ ì™„í™”í•˜ëŠ” ë°©ë²•ì„ ì—°êµ¬í•©ë‹ˆë‹¤. ì˜ˆë¥¼ ë“¤ì–´, adversarial trainingì´ë‚˜ domain adaptation ê¸°ë²•ì„ ì ìš©í•  ìˆ˜ ìˆìŠµë‹ˆë‹¤.
3. **ì¶”ë¡  ëŠ¥ë ¥ í‰ê°€:** í•©ì„±ëœ MRI ì´ë¯¸ì§€ë¥¼ ê¸°ë°˜ìœ¼ë¡œ downstream task (ì˜ˆ: ì¢…ì–‘ ë¶„ë¥˜, ë³‘ê¸° ì˜ˆì¸¡)ì˜ ì„±ëŠ¥ì„ í‰ê°€í•˜ì—¬, ëª¨ë¸ì˜ ì¶”ë¡  ëŠ¥ë ¥ì„ ì •ëŸ‰ì ìœ¼ë¡œ ì¸¡ì •í•©ë‹ˆë‹¤.
4. **Few-shot/Zero-shot í•™ìŠµ:** ì œí•œëœ ë°ì´í„°ë§Œìœ¼ë¡œ ìƒˆë¡œìš´ MRI ëª¨ë‹¬ë¦¬í‹° í•©ì„±ì„ ìˆ˜í–‰í•  ìˆ˜ ìˆëŠ” few-shot/zero-shot í•™ìŠµ ë°©ë²•ì„ ì—°êµ¬í•©ë‹ˆë‹¤.

### ğŸ“š í•µì‹¬ í‚¤ì›Œë“œ
1. **MRI Synthesis**
2. **Vision-Language Alignment (VLA)**
3. **Foundation Model**
4. **Nasopharyngeal Carcinoma (NPC)**
5. **Radiotherapy (RT)**


---

> ğŸ¤– ì´ ê¸€ì€ AI ì—°êµ¬ ì–´ì‹œìŠ¤í„´íŠ¸ì— ì˜í•´ ìë™ ìƒì„±ë˜ì—ˆìŠµë‹ˆë‹¤.
> ë¶„ì„ ëª¨ë¸: google/gemma-3-27b-it:free
